# Tiptree Inc.: financial statements, quarterly

TIPT · Nasdaq · CIK 1393726 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/tipt.md) · [Financials](/companies/tipt/financials.md) · [Filings](/companies/tipt/filings.md) · [Insiders](/companies/tipt/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/tipt/financials.md?period=annual).

## Income statement

| Line item | Unit | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [85.8](/filings/0001393726-24-000082.md) | [86.9](/filings/0001393726-24-000097.md) | [91.5 d](/filings/0001393726-25-000028.md) | [93.3](/filings/0001393726-25-000055.md) | [88.1](/filings/0001393726-25-000076.md) | [82.8](/filings/0001193125-25-259809.md) | [77.3 d](/filings/0001393726-25-000028.md) | [82.4](/filings/0001393726-25-000055.md) | [81.8](/filings/0001393726-25-000076.md) | [79.3](/filings/0001193125-25-259809.md) | [(243) d](/filings/0001393726-26-000009.md) | [0.0](/filings/0001393726-26-000026.md) |
| Selling, general and administrative | $m | [10.0](/filings/0001393726-24-000082.md) | [9.4](/filings/0001393726-24-000097.md) | [9.6 d](/filings/0001393726-25-000028.md) | [10.5](/filings/0001393726-25-000055.md) | [10.3](/filings/0001393726-25-000076.md) | [11.0](/filings/0001193125-25-259809.md) | [10.7 d](/filings/0001393726-25-000028.md) | [10.6](/filings/0001393726-25-000055.md) | [12.6](/filings/0001393726-25-000076.md) | [11.5](/filings/0001193125-25-259809.md) | not reported | not reported |
| Operating income | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | [(12.6)](/filings/0001393726-26-000026.md) | not reported | not reported | not reported | [(9.0)](/filings/0001393726-26-000026.md) |
| Interest expense | $m | [7.0](/filings/0001393726-23-000069.md) | [6.7](/filings/0001393726-23-000087.md) | [7.5 d](/filings/0001393726-24-000032.md) | [8.3](/filings/0001393726-24-000056.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [11.8](/filings/0001393726-24-000082.md) | [12.3](/filings/0001393726-24-000097.md) | [(33.9) d](/filings/0001393726-26-000009.md) | [13.8](/filings/0001393726-25-000055.md) | [18.7](/filings/0001393726-25-000076.md) | [16.3](/filings/0001193125-25-259809.md) | [(55.0) d](/filings/0001393726-26-000009.md) | [(1.6)](/filings/0001393726-26-000026.md) | [21.6](/filings/0001393726-25-000076.md) | [22.7](/filings/0001193125-25-259809.md) | [(62.3) d](/filings/0001393726-26-000009.md) | [(1.2)](/filings/0001393726-26-000026.md) |
| Net income | $m | [6.0](/filings/0001393726-24-000082.md) | [2.2](/filings/0001393726-24-000097.md) | [6.9 d](/filings/0001393726-26-000009.md) | [9.1](/filings/0001393726-25-000055.md) | [12.9](/filings/0001393726-25-000076.md) | [11.9](/filings/0001193125-25-259809.md) | [19.6 d](/filings/0001393726-26-000009.md) | [5.6](/filings/0001393726-26-000026.md) | [19.0](/filings/0001393726-25-000076.md) | [6.4](/filings/0001193125-25-259809.md) | [3.9 d](/filings/0001393726-26-000009.md) | [14.2](/filings/0001393726-26-000026.md) |
| Diluted EPS | $ per share | [0.16](/filings/0001393726-24-000082.md) | [0.04](/filings/0001393726-24-000097.md) | not reported | [0.22](/filings/0001393726-25-000055.md) | [0.31](/filings/0001393726-25-000076.md) | [0.29](/filings/0001193125-25-259809.md) | not reported | [0.13](/filings/0001393726-26-000026.md) | [0.37](/filings/0001393726-25-000076.md) | [0.13](/filings/0001193125-25-259809.md) | not reported | [0.34](/filings/0001393726-26-000026.md) |
| Basic EPS | $ per share | [0.16](/filings/0001393726-24-000082.md) | [0.06](/filings/0001393726-24-000097.md) | not reported | [0.24](/filings/0001393726-25-000055.md) | [0.35](/filings/0001393726-25-000076.md) | [0.32](/filings/0001193125-25-259809.md) | not reported | [0.15](/filings/0001393726-26-000026.md) | [0.50](/filings/0001393726-25-000076.md) | [0.17](/filings/0001193125-25-259809.md) | not reported | [0.38](/filings/0001393726-26-000026.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, us-gaap:Revenues
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [372](/filings/0001393726-23-000069.md) | [515](/filings/0001393726-23-000087.md) | [469](/filings/0001393726-25-000028.md) | [475](/filings/0001393726-24-000056.md) | [497](/filings/0001393726-24-000082.md) | [396](/filings/0001393726-24-000097.md) | [19.4](/filings/0001393726-26-000009.md) | [342](/filings/0001393726-25-000055.md) | [384](/filings/0001393726-25-000076.md) | [366](/filings/0001193125-25-259809.md) | [30.8](/filings/0001393726-26-000026.md) | [33.4](/filings/0001393726-26-000026.md) |
| Current assets | $m | not reported | not reported | not reported | not reported | not reported | not reported | [38.2](/filings/0001393726-26-000009.md) | not reported | not reported | not reported | [54.8](/filings/0001393726-26-000026.md) | [36.3](/filings/0001393726-26-000026.md) |
| Total assets | $m | [4,634](/filings/0001393726-23-000069.md) | [4,827](/filings/0001393726-23-000087.md) | [5,139](/filings/0001393726-25-000028.md) | [5,190](/filings/0001393726-24-000056.md) | [5,305](/filings/0001393726-24-000082.md) | [5,506](/filings/0001393726-24-000097.md) | [5,695](/filings/0001393726-26-000009.md) | [5,819](/filings/0001393726-25-000055.md) | [6,148](/filings/0001393726-25-000076.md) | [6,416](/filings/0001193125-25-259809.md) | [6,840](/filings/0001393726-26-000026.md) | [6,968](/filings/0001393726-26-000026.md) |
| Current liabilities | $m | not reported | not reported | not reported | not reported | not reported | not reported | [15.6](/filings/0001393726-26-000009.md) | not reported | not reported | not reported | [29.1](/filings/0001393726-26-000026.md) | [27.9](/filings/0001393726-26-000026.md) |
| Total liabilities | $m | [4,088](/filings/0001393726-23-000069.md) | [4,284](/filings/0001393726-23-000087.md) | [4,563](/filings/0001393726-25-000028.md) | [4,591](/filings/0001393726-24-000056.md) | [4,687](/filings/0001393726-24-000082.md) | [4,850](/filings/0001393726-24-000097.md) | [5,038](/filings/0001393726-26-000009.md) | [5,136](/filings/0001393726-25-000055.md) | [5,425](/filings/0001393726-25-000076.md) | [5,675](/filings/0001193125-25-259809.md) | [6,088](/filings/0001393726-26-000026.md) | [6,217](/filings/0001393726-26-000026.md) |
| Long-term debt | $m | [361](/filings/0001393726-23-000069.md) | [324](/filings/0001393726-23-000087.md) | [402](/filings/0001393726-25-000028.md) | [406](/filings/0001393726-24-000056.md) | [387](/filings/0001393726-24-000082.md) | [389](/filings/0001393726-24-000097.md) | [0.0](/filings/0001393726-26-000009.md) | [495](/filings/0001393726-25-000055.md) | [493](/filings/0001393726-25-000076.md) | [508](/filings/0001193125-25-259809.md) | [63.9](/filings/0001393726-26-000026.md) | [64.1](/filings/0001393726-26-000026.md) |
| Short-term borrowings | $m | not reported | not reported | not reported | not reported | not reported | not reported | [0.0](/filings/0001393726-26-000009.md) | not reported | not reported | not reported | [8.1](/filings/0001393726-26-000026.md) | [8.0](/filings/0001393726-26-000026.md) |
| Shareholders' equity | $m | [402](/filings/0001393726-23-000069.md) | [396](/filings/0001393726-23-000087.md) | [417](/filings/0001393726-25-000028.md) | [425](/filings/0001393726-24-000056.md) | [436](/filings/0001393726-24-000082.md) | [462](/filings/0001393726-24-000097.md) | [458](/filings/0001393726-26-000009.md) | [474](/filings/0001393726-25-000055.md) | [500](/filings/0001393726-25-000076.md) | [505](/filings/0001193125-25-259809.md) | [509](/filings/0001393726-26-000026.md) | [504](/filings/0001393726-26-000026.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt, us-gaap:LongTermDebtNoncurrent
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(6.7) d](/filings/0001393726-24-000082.md) | [57.2 d](/filings/0001393726-24-000097.md) | [(22.1) d](/filings/0001393726-26-000009.md) | [62.7](/filings/0001393726-25-000055.md) | [46.9 d](/filings/0001393726-25-000076.md) | [61.2 d](/filings/0001193125-25-259809.md) | [70.0 d](/filings/0001393726-26-000009.md) | [(33.3)](/filings/0001393726-26-000026.md) | [21.3 d](/filings/0001393726-25-000076.md) | [135 d](/filings/0001193125-25-259809.md) | [44.9 d](/filings/0001393726-26-000009.md) | [(18.2)](/filings/0001393726-26-000026.md) |
| Capital expenditure | $m | [6.6 d](/filings/0001393726-24-000082.md) | [0.9 d](/filings/0001393726-24-000097.md) | [(8.4) d](/filings/0001393726-26-000009.md) | [0.8](/filings/0001393726-25-000055.md) | [0.9 d](/filings/0001393726-25-000076.md) | [0.5 d](/filings/0001193125-25-259809.md) | [(2.2) d](/filings/0001393726-26-000009.md) | [1.1](/filings/0001393726-25-000055.md) | [1.2 d](/filings/0001393726-25-000076.md) | [2.1 d](/filings/0001193125-25-259809.md) | [(4.4) d](/filings/0001393726-26-000009.md) | not reported |
| Dividends paid | $m | [3.4 d](/filings/0001393726-24-000082.md) | [3.4 d](/filings/0001393726-24-000097.md) | [(2.9) d](/filings/0001393726-26-000009.md) | [3.8](/filings/0001393726-25-000055.md) | [3.9 d](/filings/0001393726-25-000076.md) | [3.8 d](/filings/0001193125-25-259809.md) | [6.7 d](/filings/0001393726-26-000009.md) | [2.3](/filings/0001393726-26-000026.md) | [5.5 d](/filings/0001393726-25-000076.md) | [3.9 d](/filings/0001193125-25-259809.md) | [(2.5) d](/filings/0001393726-26-000009.md) | [2.3](/filings/0001393726-26-000026.md) |
| Share repurchases | $m | not reported | [0.0 d](/filings/0001393726-23-000087.md) | [0.0 d](/filings/0001393726-25-000028.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q2 FY2022 (2022-06-30) | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [35.2](/filings/0001393726-23-000069.md) | [36.8](/filings/0001393726-23-000087.md) | [36.5](/filings/0001393726-24-000056.md) | [37.6](/filings/0001393726-24-000082.md) | [37.7](/filings/0001393726-24-000097.md) | [37.8](/filings/0001393726-25-000055.md) | [37.8](/filings/0001393726-25-000076.md) | [37.8](/filings/0001193125-25-259809.md) | [37.3](/filings/0001393726-26-000026.md) | [38.6](/filings/0001393726-25-000076.md) | [38.6](/filings/0001193125-25-259809.md) | [37.8](/filings/0001393726-26-000026.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 37,570,075 at 2026-04-29, from the cover of the [10-Q filed 2026-04-30](/filings/0001393726-26-000026.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:38 ET. No prices; not investment advice.